Abivax SA: updates and filings

ABVXNASDAQHealthcare · Pharmaceutical Preparations

Price

$73.20

November 20, 2026Market cap $5.7B

What Ploutos Investor adds for Abivax SA

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 5 fiscal years, from 2021
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Mar 23, 2026 latest annual
  • Nov 16, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Sep 21, 2026Filing
    FormF-6EF
  • Sep 21, 2026Current report (foreign company)
    Form6-K
  • Aug 14, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 13, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jul 6, 2026Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A
  • Jul 2, 2026Current report (foreign company)
    Form6-K
  • Jun 30, 2026Filing
    FormPOSASR
  • Jun 29, 2026Current report (foreign company)
    Form6-K
  • Jun 2, 2026Current report (foreign company)
    Form6-K
  • May 22, 2026Current report (foreign company)
    Form6-K
  • May 20, 2026Current report (foreign company)
    Form6-K
  • May 11, 2026Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A
  • May 7, 2026Current report (foreign company)
    Form6-K
  • Apr 20, 2026Current report (foreign company)
    Form6-K
  • Mar 23, 2026Shares registered for employees
    FormS-8
  • Mar 23, 2026Annual report (foreign company)for the period to Dec 31, 2025
    Form20-F
  • Mar 23, 2026Current report (foreign company)
    Form6-K
  • Feb 23, 2026Current report (foreign company)
    Form6-K
  • Feb 13, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jan 14, 2026Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A
  • Dec 15, 2025Current report (foreign company)
    Form6-K
  • Nov 14, 2025Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Nov 14, 2025Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 30, 2025Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 16, 2022.

The full analysis

What do Abivax SA's filings show?

The filings are where every one of Abivax SA's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.